Proxalutamide Treatment for COVID-19 Female Outpatients

NCT04853134 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped This study was combined with another study

Conditions

Interventions

Sponsor

Applied Biology, Inc.